Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Combined With Monoclonal Antibody in Locally Advanced NSCLC
Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Combined With Monoclonal Antibody in Locally Advanced NSCLC
Recruiting · NCT07863999 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Combined With Monoclonal Antibody in Locally Advanced NSCLC | Locally Advanced Non-Small Cell Lung Cancer | Recruiting | Phase 3 | 2026-10-07 | NCT07863999 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Pulmonary Hospital, Shanghai, China | 98 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Huadong Hospital Affiliated to Fudan University | Shanghai | China | 1 |
| Shanghai Changzheng Hospital | Shanghai | China | 1 |
| Shanghai General Hospital | Shanghai | China | 1 |
| Shanghai Pulmonary Hospital | Shanghai | China | 2 |
| Tongji Hospital of Tongji University | Shanghai | China | 1 |